Self‐injectable DMTs in relapsing MS: NEDA assessment at 10 years in a real‐world cohort
Sign Up to like & getrecommendations! Published in 2022 at "Acta Neurologica Scandinavica"
DOI: 10.1111/ane.13582
Abstract: Multiple sclerosis (MS) is an immune‐mediated disorder of the central nervous system. DMTs effectively reduce the annual relapse rate—thus reducing disease activity—and, to a lesser extent, some DMTs prevent disease progression in some people with… read more here.
Keywords: neda assessment; relapsing neda; dmts; injectable dmts ... See more keywords